172 F.Supp.2d 1018 (S.D.Ill. 2001), 96-CV-4113, Caraker v. Sandoz Pharmaceuticals Corp.
Linked as:
Extract
172 F.Supp.2d 1018 (S.D.Ill. 2001), 96-CV-4113, Caraker v. Sandoz Pharmaceuticals Corp.
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Personnel, medical, and similar files, disclosure of which constitutes a clearly unwarranted invasion of personal privacy
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products described in section 201.56(b)(1)
- Code of Federal Regulations - Supplements and other changes to an approved NDA
- US Code - 21 U.S.C. § 360k State and Local Requirements Respecting Devices
- Federal Cases - Kociemba v. GD Searle & Co.
